Literature DB >> 20697516

A case for tobacco content regulation by the U.S. Food and Drug Administration.

J A du Toit1.   

Abstract

Although many people welcome the recent move by the United States to give its Food and Drug Administration (FDA) the authority to regulate the content of tobacco, some worry that such regulation constitutes unwarranted interference with the freedom of competent adult tobacco consumers. The concern for protecting the autonomy of individuals is valuable indeed, but given the highly addictive nature of tobacco products (and especially the nicotine in tobacco products), the continued use of tobacco by smokers cannot -without straining credulity-be said to be autonomous. This fact, combined with a proper construal of the FDA's role and an appreciation of the substantial morbidity and mortality associated with tobacco use, makes a strong case for content regulation.

Entities:  

Keywords:  Tobacco; autonomy; bioethics; fda; nicotine

Year:  2010        PMID: 20697516      PMCID: PMC2913831          DOI: 10.3747/co.v17i4.552

Source DB:  PubMed          Journal:  Curr Oncol        ISSN: 1198-0052            Impact factor:   3.677


  1 in total

1.  The legal and scientific basis for FDA's assertion of jurisdiction over cigarettes and smokeless tobacco.

Authors:  D A Kessler; P S Barnett; A Witt; M R Zeller; J R Mande; W B Schultz
Journal:  JAMA       Date:  1997-02-05       Impact factor: 56.272

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.